Stable Gastric Pentadecapeptide BPC 157 Therapy Key Findings: BPC-157 has demonstrated consistent healing of various gastrointestinal fistulas, both external and internal, in rats
The authors themselves described it as a small preliminary study.[15] A 2025 pilot report described intravenous administration to two healthy adults at doses up to 20 mg, with no measurable changes in cardiac, hepatic, renal or thyroid biomarkers and no reported adverse effects.[16] Two individuals cannot characterise uncommon reactions, immunogenicity, long-term toxicity, reproductive safety or oncological risk
Every ingredient meets strict purity and potency standards
"Comparative Bioavailability and Utilization of Particular Forms of B12 Supplements With Potential to Mitigate B12-related Genetic Polymorphisms"
Michael Genovese, M.D., is a board-certified physician and the Chief Medical Advisor at Ascendant New York
Dihexa Therapy Advanced cognitive support for sharper, stronger thinking